With the sale of Aptuit's Clinical Trials Supply business to Catalent Pharma Solutions, Aptuit continues its focus on scientific and service excellence in the early to mid-phase drug development market. Our capabilities now feature:
| • Drug Design and Discovery • Preclinical Biosciences • API Development and Manufacture • Solid State Chemistry • Solid, Oral and Sterile Dosage Form Development and Manufacture • Clinical Sciences • Aptuit Consulting • Aptuit INDiGO®, our proprietary program for fast track IND submission |
Aptuit holds a best in class position in several of these key development areas, which are available as an integrated service offering or on a stand-alone basis.
Since our earliest days, we have been dedicated to engineering a better drug development process through scientific excellence. Our previously implemented service performance initiative continues to drive every level of our organization. Aptuit people join their heads for science and their hearts for service to help clients realize their goals - as efficiently, expeditiously and cost effectively as possible, always at the highest level of quality and compliance.
You'll find more information about our capabilities here.
You can also contact us with any questions or comments that you may have at info@aptuit.com, or call +39 045 821 9333 in Europe or 855-506-6360 in the US.
No comments:
Post a Comment